임상시험용 자재 및 소모품 시장 규모, 점유율, 성장 분석 : 서비스별, 단계별, 유형별, 치료 영역별, 지역별 - 업계 예측(2026-2033년)

Global Clinical Trial Materials And Supplies Market size was valued at USD 3.84 Billion in 2024 and is poised to grow from USD 4.22 Billion in 2025 to USD 8.91 Billion by 2033, growing at a CAGR of 9.8% during the forecast period (2026-2033).

The management of clinical trial supplies is essential to avoid challenges like inventory expiration and overproduction, particularly as the costs of drug detection rise. An efficient supply chain is crucial for navigating the complexities of clinical research while adhering to regulatory demands. The market for clinical trial materials is driven by the increasing number and intricacy of clinical studies. Supplies include various tools vital for medical trials, such as infusion pumps, nebulizers, and syringe needles, used for diagnosing and treating diseases, evaluating therapies, and supporting various medical operations. As drug developers outsource their clinical trial supplies to investigator sites, the market is experiencing accelerated growth, fueled by technological advancements, strategic collaboration among providers, and an uptick in patent expirations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clinical Trial Materials And Supplies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clinical Trial Materials And Supplies Market Segments Analysis

Global Clinical Trial Materials And Supplies Market is segmented by service, phase, type, therapeutic area, end user and region. Based on service, the market is segmented into logistics & distribution, storage & retention, packaging, labelling & blinding, manufacturing, comparator sourcing and other services. Based on phase, the market is segmented into Phase I, Phase II, Phase III, Phase IV, BA/BE Studies. Based on type, the market is segmented into small-molecules, biologic drugs and medical devices. Based on therapeutic area, the market is segmented into oncology, infectious diseases, neurology, metabolic disorders, immunology, cardiology, genetic diseases and other therapeutic areas. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, contract research organisations (CRO's) and medical device companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clinical Trial Materials And Supplies Market

The expansion of the Global Clinical Trial Materials and Supplies market is significantly driven by an increase in patient participation in clinical trials in emerging nations such as China, India, and South Korea, where costs are substantially lower compared to developed countries. In these regions, early-phase clinical trials can be considerably less expensive, creating an attractive environment for conducting research, particularly for rare diseases. Furthermore, the advancement of technology and data analytics plays a crucial role in streamlining clinical trial processes, encouraging pharmaceutical and biotechnology companies to outsource innovative solutions. This shift towards developing countries for clinical trials enhances efficiency and encourages collaboration within the industry.

Restraints in the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market faces significant challenges due to the high attrition rates of drug candidates during development, which leads to considerable financial burdens in research and development. The complexity of R&D for rare diseases often requires specialized expertise to successfully conduct clinical trials, further complicating the process. A striking number of drugs, particularly in the field of oncology, fail to secure regulatory approval after reaching clinical testing stages. Furthermore, the lengthy timeline and escalating costs involved in bringing a new drug from discovery to market approval act as major obstacles, hindering the overall growth and expansion of the market.

Market Trends of the Global Clinical Trial Materials And Supplies Market

The Global Clinical Trial Materials and Supplies market is witnessing a notable shift towards biologics and temperature-sensitive medications, driven by their therapeutic advantages, such as lower side effects compared to traditional therapies. With biologics constituting a significant percentage of late-phase pharmaceutical developments and a substantial portion of existing drugs requiring temperature-controlled environments, the market is expected to respond dynamically to these trends. This growing reliance on cold chain logistics underscores the necessity for enhanced infrastructure and innovative solutions in the supply chain to ensure the integrity and efficacy of these sensitive products. As such, investments in cold chain facilities and advanced monitoring technologies are poised to surge, shaping the future landscape of clinical trial materials and supplies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Supply Chain Analysis
• Technology Analysis
• Regulatory Analysis

Global Clinical Trial Materials And Supplies Market Size by Service & CAGR (2026-2033)

• Market Overview
• Logistics & Distribution
• Storage & Retention
• Packaging, Labelling & Blinding
• Manufacturing
• Comparator Sourcing
• Other Services

Global Clinical Trial Materials And Supplies Market Size by Phase & CAGR (2026-2033)

• Market Overview
• Phase I
• Phase II
• Phase III
• Phase IV
• BA/BE Studies

Global Clinical Trial Materials And Supplies Market Size by Type & CAGR (2026-2033)

• Market Overview
• Small-Molecules
• Biologic Drugs
• Medical Devices

Global Clinical Trial Materials And Supplies Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Infectious Diseases
• Neurology
• Metabolic Disorders
• Immunology
• Cardiology
• Genetic Diseases
• Other Therapeutic Areas

Global Clinical Trial Materials And Supplies Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical And Biotechnology Companies
• Contract Research Organisations (CRO's)
• Medical Device Companies

Global Clinical Trial Materials And Supplies Market Size & CAGR (2026-2033)

• North America (Service, Phase, Type, Therapeutic Area, End User)
  • US
  • Canada
• Europe (Service, Phase, Type, Therapeutic Area, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service, Phase, Type, Therapeutic Area, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service, Phase, Type, Therapeutic Area, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service, Phase, Type, Therapeutic Area, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
• Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Catalent, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Pharma Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Almac Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marken (A Subsidiary of UPS)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sharp Services, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvisan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celerion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recipharm AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tunnell Consulting
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aesica Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kendle International (Now a part of INC Research)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetter Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations